(CPT) Camden Property Trust - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1331311027
Stock: Multifamily, Apartments, Leasing, Development
Total Rating 32
Risk 77
Buy Signal 0.17
Dividends
| Dividend Yield | 3.74% |
| Yield on Cost 5y | 4.68% |
| Yield CAGR 5y | 6.05% |
| Payout Consistency | 96.3% |
| Payout Ratio | 3.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 21.4% |
| Relative Tail Risk | -0.56% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.37 |
| Alpha | -14.87 |
| Character TTM | |
|---|---|
| Beta | 0.509 |
| Beta Downside | 0.708 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.82% |
| CAGR/Max DD | -0.02 |
Description: CPT Camden Property Trust January 04, 2026
Camden Property Trust (NYSE:CPT) is an S&P 500-listed REIT that focuses on the ownership, management, development, acquisition, and construction of multifamily apartment communities across the United States. The company currently operates 174 properties comprising 59,416 apartment homes, and it will expand to 177 properties and 60,578 homes once three projects under construction are completed.
Key operating metrics that signal the firm’s recent performance include a FY 2023 occupancy rate of roughly 96%, same-store net operating income (NOI) growth of about 6% year-over-year, and an average rent increase of 4% YoY, reflecting strong demand in core markets despite a higher-for-long interest-rate environment. The pipeline contains roughly $2.5 billion of capital projects slated for the next 12-18 months, underscoring Camden’s emphasis on supply-side expansion while maintaining disciplined leverage.
For a deeper, data-driven view of how these fundamentals stack up against sector peers, you might find ValueRay’s analytical dashboards worth exploring.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 384.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 2.93 > 1.0 |
| NWC/Revenue: 2.83% < 20% (prev -23.71%; Δ 26.54% < -1%) |
| CFO/TA 0.07 > 3% & CFO 629.8m > Net Income 384.5m |
| Net Debt (-25.2m) to EBITDA (1.11b): -0.02 < 3 |
| Current Ratio: 55.52 > 1.5 & < 3 |
| Outstanding Shares: last quarter (108.6m) vs 12m ago 0.09% < -2% |
| Gross Margin: 61.15% > 18% (prev 0.61%; Δ 6054 % > 0.5%) |
| Asset Turnover: 13.47% > 50% (prev 17.44%; Δ -3.97% > 0%) |
| Interest Coverage Ratio: 4.78 > 6 (EBITDA TTM 1.11b / Interest Expense TTM 104.2m) |
Altman Z'' 0.03
| A: 0.00 (Total Current Assets 34.1m - Total Current Liabilities 614.0k) / Total Assets 8.70b |
| B: -0.12 (Retained Earnings -1.01b / Total Assets 8.70b) |
| C: 0.06 (EBIT TTM 498.3m / Avg Total Assets 8.78b) |
| D: 0.00 (Book Value of Equity 3.32m / Total Liabilities 4.60b) |
| Altman-Z'' Score: 0.03 = B |
What is the price of CPT shares?
As of February 10, 2026, the stock is trading at USD 107.88 with a total of 980,723 shares traded.
Over the past week, the price has changed by +0.54%, over one month by -0.85%, over three months by +6.41% and over the past year by -6.12%.
Over the past week, the price has changed by +0.54%, over one month by -0.85%, over three months by +6.41% and over the past year by -6.12%.
Is CPT a buy, sell or hold?
Camden Property Trust has received a consensus analysts rating of 3.68.
Therefor, it is recommend to hold CPT.
- StrongBuy: 8
- Buy: 2
- Hold: 14
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the CPT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 115.3 | 6.8% |
| Analysts Target Price | 115.3 | 6.8% |
| ValueRay Target Price | 117.1 | 8.5% |
CPT Fundamental Data Overview February 09, 2026
P/E Trailing = 30.1215
P/E Forward = 72.4638
P/S = 7.1636
P/B = 2.6056
P/EG = 8.96
Revenue TTM = 1.18b USD
EBIT TTM = 498.3m USD
EBITDA TTM = 1.11b USD
Long Term Debt = 3.31b USD (from longTermDebt, two quarters ago)
Short Term Debt = 429.6m USD (from shortTermDebt, two quarters ago)
Debt = 3.74b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -25.2m USD (from netDebt column, last quarter)
Enterprise Value = 15.08b USD (11.37b + Debt 3.74b - CCE 25.2m)
Interest Coverage Ratio = 4.78 (Ebit TTM 498.3m / Interest Expense TTM 104.2m)
EV/FCF = 23.95x (Enterprise Value 15.08b / FCF TTM 629.8m)
FCF Yield = 4.18% (FCF TTM 629.8m / Enterprise Value 15.08b)
FCF Margin = 53.25% (FCF TTM 629.8m / Revenue TTM 1.18b)
Net Margin = 32.51% (Net Income TTM 384.5m / Revenue TTM 1.18b)
Gross Margin = 61.15% ((Revenue TTM 1.18b - Cost of Revenue TTM 459.5m) / Revenue TTM)
Gross Margin QoQ = none% (prev 60.69%)
Tobins Q-Ratio = 1.73 (Enterprise Value 15.08b / Total Assets 8.70b)
Interest Expense / Debt = 0.94% (Interest Expense 35.0m / Debt 3.74b)
Taxrate = 21.0% (US default 21%)
NOPAT = 393.6m (EBIT 498.3m * (1 - 21.00%))
Current Ratio = 55.52 (Total Current Assets 34.1m / Total Current Liabilities 614.0k)
Debt / Equity = 0.86 (Debt 3.74b / totalStockholderEquity, last quarter 4.36b)
Debt / EBITDA = -0.02 (Net Debt -25.2m / EBITDA 1.11b)
Debt / FCF = -0.04 (Net Debt -25.2m / FCF TTM 629.8m)
Total Stockholder Equity = 4.53b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.38% (Net Income 384.5m / Total Assets 8.70b)
RoE = 8.50% (Net Income TTM 384.5m / Total Stockholder Equity 4.53b)
RoCE = 6.36% (EBIT 498.3m / Capital Employed (Equity 4.53b + L.T.Debt 3.31b))
RoIC = 4.72% (NOPAT 393.6m / Invested Capital 8.35b)
WACC = 6.04% (E(11.37b)/V(15.11b) * Re(7.79%) + D(3.74b)/V(15.11b) * Rd(0.94%) * (1-Tc(0.21)))
Discount Rate = 7.79% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.77%
[DCF Debug] Terminal Value 87.84% ; FCFF base≈530.3m ; Y1≈648.4m ; Y5≈1.08b
Fair Price DCF = 282.2 (EV 30.05b - Net Debt -25.2m = Equity 30.08b / Shares 106.6m; r=6.04% [WACC]; 5y FCF grow 23.81% → 2.90% )
EPS Correlation: -42.00 | EPS CAGR: -2.17% | SUE: 0.05 | # QB: 0
Revenue Correlation: 70.36 | Revenue CAGR: 7.09% | SUE: -1.54 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.30 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=1.11 | Chg30d=-0.137 | Revisions Net=-1 | Growth EPS=-13.4% | Growth Revenue=+1.5%
EPS next Year (2027-12-31): EPS=1.97 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+77.4% | Growth Revenue=+4.0%
P/E Forward = 72.4638
P/S = 7.1636
P/B = 2.6056
P/EG = 8.96
Revenue TTM = 1.18b USD
EBIT TTM = 498.3m USD
EBITDA TTM = 1.11b USD
Long Term Debt = 3.31b USD (from longTermDebt, two quarters ago)
Short Term Debt = 429.6m USD (from shortTermDebt, two quarters ago)
Debt = 3.74b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -25.2m USD (from netDebt column, last quarter)
Enterprise Value = 15.08b USD (11.37b + Debt 3.74b - CCE 25.2m)
Interest Coverage Ratio = 4.78 (Ebit TTM 498.3m / Interest Expense TTM 104.2m)
EV/FCF = 23.95x (Enterprise Value 15.08b / FCF TTM 629.8m)
FCF Yield = 4.18% (FCF TTM 629.8m / Enterprise Value 15.08b)
FCF Margin = 53.25% (FCF TTM 629.8m / Revenue TTM 1.18b)
Net Margin = 32.51% (Net Income TTM 384.5m / Revenue TTM 1.18b)
Gross Margin = 61.15% ((Revenue TTM 1.18b - Cost of Revenue TTM 459.5m) / Revenue TTM)
Gross Margin QoQ = none% (prev 60.69%)
Tobins Q-Ratio = 1.73 (Enterprise Value 15.08b / Total Assets 8.70b)
Interest Expense / Debt = 0.94% (Interest Expense 35.0m / Debt 3.74b)
Taxrate = 21.0% (US default 21%)
NOPAT = 393.6m (EBIT 498.3m * (1 - 21.00%))
Current Ratio = 55.52 (Total Current Assets 34.1m / Total Current Liabilities 614.0k)
Debt / Equity = 0.86 (Debt 3.74b / totalStockholderEquity, last quarter 4.36b)
Debt / EBITDA = -0.02 (Net Debt -25.2m / EBITDA 1.11b)
Debt / FCF = -0.04 (Net Debt -25.2m / FCF TTM 629.8m)
Total Stockholder Equity = 4.53b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.38% (Net Income 384.5m / Total Assets 8.70b)
RoE = 8.50% (Net Income TTM 384.5m / Total Stockholder Equity 4.53b)
RoCE = 6.36% (EBIT 498.3m / Capital Employed (Equity 4.53b + L.T.Debt 3.31b))
RoIC = 4.72% (NOPAT 393.6m / Invested Capital 8.35b)
WACC = 6.04% (E(11.37b)/V(15.11b) * Re(7.79%) + D(3.74b)/V(15.11b) * Rd(0.94%) * (1-Tc(0.21)))
Discount Rate = 7.79% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.77%
[DCF Debug] Terminal Value 87.84% ; FCFF base≈530.3m ; Y1≈648.4m ; Y5≈1.08b
Fair Price DCF = 282.2 (EV 30.05b - Net Debt -25.2m = Equity 30.08b / Shares 106.6m; r=6.04% [WACC]; 5y FCF grow 23.81% → 2.90% )
EPS Correlation: -42.00 | EPS CAGR: -2.17% | SUE: 0.05 | # QB: 0
Revenue Correlation: 70.36 | Revenue CAGR: 7.09% | SUE: -1.54 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.30 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=1.11 | Chg30d=-0.137 | Revisions Net=-1 | Growth EPS=-13.4% | Growth Revenue=+1.5%
EPS next Year (2027-12-31): EPS=1.97 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+77.4% | Growth Revenue=+4.0%